Duran Duran guitarist Andy Taylor is sharing some optimistic information about his battle with most cancers.
The 62-year-old musician, who revealed his stage 4 prostate most cancers analysis in November 2022 (he was initially identified in 2018), says he expects to dwell one other 5 years because of a “nuclear drugs” referred to as Lutetium-177.
Taylor tells BBC Breakfast that scientists contacted him in regards to the drug, which is designed to designed to particularly goal most cancers cells.
“It will possibly’t see wholesome cells,” says Taylor, who had his first therapy about six weeks in the past. “It kills stage 4 most cancers in your bones. And so what it’s successfully executed is lengthen my life for 5 years.”
Lutetium-177 was authorized by the U.S. Meals and Drug Administration in March 2022. The drug has “confirmed to considerably enhance prostate most cancers survival charges and high quality of life, in addition to lengthen the time it takes for the illness to progress,” in accordance with the College of Chicago Medical Middle.
Taylor revealed his most cancers analysis by way of a letter learn by his bandmates throughout their induction into the Rock & Roll Corridor final November. The guitarist was anticipated to affix members Simon LeBon, John Taylor, Nick Rhodes and Roger Taylor on the group’s induction in Los Angeles, however needed to miss it on account of his sickness.
Taylor instructed BBC that he was “massively disillusioned” to overlook the Rock Corridor ceremony, which he known as “the largest night time of my life.”
The guitarist says the Lutetium-177 therapy is permitting him to complete his upcoming solo album, Man’s a Wolf to Man, which is scheduled for launch in September.
Earlier this 12 months, Duran Duran confirmed that Taylor can be contributing to the group’s forthcoming album. The band can also be honoring the guitarist with a one-off profit live performance for most cancers consciousness on the Guild Theatre in Menlo Park, Calif., on Aug. 19.
